000806.SZ Stock Analysis
00
Uncovered
Galaxy Biomedical Investment Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Galaxy Biomedical Investment Co., Ltd. engages in the provision of investment in bio-pharmaceutical industry, transmission and distribution system industry, and electronic information industry. The company is headquartered in Beihai, Guangxi and currently employs 1,991 full-time employees. The firm mainly operates through three business segments. Biomedical segment is mainly engaged in the research and development of innovative drugs, model animal construction, tumor immune cell therapy and the development of stem cell technology. Electricity Transmission and Distribution segment is mainly engaged in the manufacture and sale of transformer products in various specifications and types. Electronic segment mainly provides various types of displacement sensors, brake resistance boxes, radio frequency (RF) components, resistors and potentiometers, among others. The firm distributes its products mainly in domestic market, with eastern China as its main market.